Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Blood Specimen Collection × NET × Clear all

Phase

Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 62 Breast 45 Thoracic 44 Gynecologic 33 Genitourinary 27 Tumor-Agnostic 25 Other hematologic neoplasm 24 Lymphoid 23 CNS 21 Head & Neck 20 Dermatologic 17 Sarcoma 12 Plasma cell 9 Myeloid 5 Other solid neoplasm 3 NET 1 Endocrine 1 Classical hematology 1

Conditions

Midgut Neuroendocrine Tumors 1

Interventions

lutetium Lu 177 dotatate 2 Lutetium-177 2 Liquid Biopsy 2 Endoscopic Mucosal Resection 2 Data Collection 2 pentetreotide 1 fluorodopa F 18 1 copper dotatate CU-64 1 Yttrium-90 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Specimen Handling 1 Single Photon Emission Computed Tomography Computed Tomography 1 Serum Albumin 1 Robotic Surgical Procedures 1 Resveratrol 1 Respiratory Therapy 1 Referral and Consultation 1 Radiofrequency Ablation 1 Quality of Life 1 Poly(ADP-ribose) Polymerase Inhibitors 1 Palliative Care 1 Octreotide 1 Nutrition Assessment 1 Needles 1 Magnetic Resonance Spectroscopy 1 Laparoscopy 1 Drug Therapy 1 Diet Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03667092 2025-04-10

GENEBIOLuNET

University Hospital, Toulouse

Phase NA Completed

Midgut Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡